Vijayaraj P, Minasyan A, Durra A, Karumbayaram S, Mehrabi M, Aros C, et al. Modeling Progressive Fibrosis with Pluripotent Stem Cells Identifies an Anti-fibrotic Small Molecule. Cell Rep. 2019;29:3488-3505.e9 pubmed publisher

Pandolfi E, Rojas E, Sosa E, Gell J, Hunt T, Goldsmith S, et al. Generation of three human induced pluripotent stem cell sublines (MZT04D, MZT04J, MZT04C) for reproductive science research. Stem Cell Res. 2019;40:101576 pubmed publisher

Brookhouser N, Zhang P, Caselli R, Kim J, Brafman D. Generation and characterization of two human induced pluripotent stem cell (hiPSC) lines homozygous for the Apolipoprotein e4 (APOE4) risk variant-Alzheimer's disease (ASUi005-A) and healthy non-demented control (ASUi006-A). Stem Cell Res. 2018;32:145-149 pubmed publisher

Dejosez M, Zwaka T. Generation of hiPSTZ16 (ISMMSi003-A) cell line from normal human foreskin fibroblasts. Stem Cell Res. 2018;26:44-46 pubmed publisher

Terray A, Fort V, Slembrouck A, Nanteau C, Sahel J, Reichman S, et al. Establishment of an induced pluripotent stem (iPS) cell line from dermal fibroblasts of an asymptomatic patient with dominant PRPF31 mutation. Stem Cell Res. 2017;25:26-29 pubmed publisher

Brookhouser N, Zhang P, Caselli R, Kim J, Brafman D. Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi001-A) and non-demented control (ASUi002-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant. Stem Cell Res. 2017;24:160-163 pubmed publisher

Terray A, Slembrouck A, Nanteau C, Chondroyer C, Zeitz C, Sahel J, et al. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene. Stem Cell Res. 2017;24:1-4 pubmed publisher

Matsuoka Y, Nakatsuka R, Sumide K, Kawamura H, Takahashi M, Fujioka T, et al. Prospectively Isolated Human Bone Marrow Cell-Derived MSCs Support Primitive Human CD34-Negative Hematopoietic Stem Cells. Stem Cells. 2015;33:1554-65 pubmed publisher

Zhu H, Hu S, Baker J. JMJD5 regulates cell cycle and pluripotency in human embryonic stem cells. Stem Cells. 2014;32:2098-110 pubmed publisher

Li O, Tormin A, Sundberg B, Hyllner J, Le Blanc K, Scheding S. Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies. PLoS ONE. 2013;8:e55319 pubmed publisher

Sarkadi B, Orban T, Szakacs G, Várady G, Schamberger A, Erdei Z, et al. Evaluation of ABCG2 expression in human embryonic stem cells: crossing the same river twice?. Stem Cells. 2010;28:174-6 pubmed publisher

Lee J, Lee J, Kim D, Yoon T, Chung H, Lee D. High concentration of synthetic serum, stepwise equilibration and slow cooling as an efficient technique for large-scale cryopreservation of human embryonic stem cells. Fertil Steril. 2010;93:976-85 pubmed publisher

Neganova I, Zhang X, Atkinson S, Lako M. Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells. Oncogene. 2009;28:20-30 pubmed publisher